CoChat

A Novel Type of Blood Biomarker: Distinct Changes of Cytokine-Induced STAT Phosphorylation in Blood T Cells Between Colorectal Cancer Patients and Healthy Individuals

Open access

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Abstract

Background: Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths worldwide. Although early diagnosis and treatment is the most successful strategy for improving patient survival, feasible and sensitive blood biomarkers for CRC screening remain elusive. Methods: Sixty-five CRC patients and thirty-three healthy individuals were enrolled. Peripheral blood (PB) and tumor tissues from CRC patients, and PB from healthy individuals were subjected to immunophenotyping and phospho-flow analysis of cytokine-induced phosphorylated STAT (CIPS). Logistic regression was used as a classifier that separates CRC patients from healthy individuals. Results: The proportion of regulatory T cells was increased in PB from CRC patients compared to PB from healthy individuals (p < 0.05). Interestingly, peripheral T cells share several cytokine-induced phosphorylated STAT (CIPS) signatures with T cells from CRC tumor-sites. Additionally, a classifier was made using two signatures distinct between T cells from CRC patients and T cells from healthy individuals. The AUCs (area under curves) of the classifier were 0.88 in initial cohort and 0.94 in the additional validation cohort. Overall AUC was 0.94 with sensitivity of 91% and specificity of 88%. Conclusion: This study highlights that immune cell signatures in peripheral blood could offer a new type of biomarker for CRC screening.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cancers11081157

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 (A–F) Lymphocyte subsets in tumor infiltrating lymphocytes (TILs) and peripheral blood mononuclear cells (PBMCs) from colorectal patients (n = 50) by flow cytometry. (D) Regulatory T (Treg) cells of tumor infiltrating Th cells were proportionally significantly increased. In PBMCs from colorectal cancer (CRC) patients, the proportion of Treg cells in Th cells was also significantly increased. (E) The proportion of NK cells decreased in TILs. (G) Graphic visualization summarizing the lymphocyte subset results. CON, control peripheral blood mononuclear cells from healthy blood donors; PBMC, peripheral blood mononuclear cells from colorectal cancer patients; TILs, tumor-infiltrating lymphocytes from colorectal cancer patients.; Th, helper T cell; Tc, cytotoxic T cell; Treg, regulatory T cell; *, p values < 0.05; **, p values < 0.01 in Mann-Whitney-Wilcoxon test; middle line in box plot represents median and upper and lower sides are 1st and 3rd quantiles, respectively. Whiskers above and below the box plot represents values exceeding the 1st–3rd quantile range.
Figure 1 (A–F) Lymphocyte subsets in tumor infiltrating lymphocytes (TILs) and peripheral blood mononuclear cells (PBMCs) from colorectal patients (n = 50) by flow cytometry. (D) Regulatory T (Treg) cells of tumor infiltrating Th cells were proportionally significantly increased. In PBMCs from colorectal cancer (CRC) patients, the proportion of Treg cells in Th cells was also significantly increased. (E) The proportion of NK cells decreased in TILs. (G) Graphic visualization summarizing the lymphocyte subset results. CON, control peripheral blood mononuclear cells from healthy blood donors; PBMC, peripheral blood mononuclear cells from colorectal cancer patients; TILs, tumor-infiltrating lymphocytes from colorectal cancer patients.; Th, helper T cell; Tc, cytotoxic T cell; Treg, regulatory T cell; *, p values < 0.05; **, p values < 0.01 in Mann-Whitney-Wilcoxon test; middle line in box plot represents median and upper and lower sides are 1st and 3rd quantiles, respectively. Whiskers above and below the box plot represents values exceeding the 1st–3rd quantile range.CC BY · PubMed Central
Figure 2 Cytokine induced phosphorylated STAT (CIPS) signatures in peripheral blood mononuclear cells (PBMCs) and tumor infiltrating lymphocytes (TILs) from colorectal cancer (CRC) patients (n = 50). Phospho-flow cytometry was performed in combination for IL-6 and STAT1 (A), IL-6 and STAT3 (B), IL-10 and STAT10 (C), and IL-2 and STAT5 (D). In the first three plots (from the left), CIPS signatures were tested in helper T cells, regulatory T cells, and cytotoxic T cells. To the far right is a visualization summarizing each CIPS signature. CON, control peripheral blood mononuclear cells from healthy blood donors; PBMC, peripheral blood mononuclear cells from colorectal cancer patients; TILs, tumor-infiltrating lymphocytes from colorectal cancer patients; CRC, colorectal cancer.; *, p-values < 0.05; **, p-values < 0.01 in Mann-Whitney-Wilcoxon test; middle line in box plot represents median and upper and lower sides are 1st and 3rd quantiles, respectively. Whiskers above and below the box plot represents values exceeding the 1st–3rd quantile range.
Figure 2 Cytokine induced phosphorylated STAT (CIPS) signatures in peripheral blood mononuclear cells (PBMCs) and tumor infiltrating lymphocytes (TILs) from colorectal cancer (CRC) patients (n = 50). Phospho-flow cytometry was performed in combination for IL-6 and STAT1 (A), IL-6 and STAT3 (B), IL-10 and STAT10 (C), and IL-2 and STAT5 (D). In the first three plots (from the left), CIPS signatures were tested in helper T cells, regulatory T cells, and cytotoxic T cells. To the far right is a visualization summarizing each CIPS signature. CON, control peripheral blood mononuclear cells from healthy blood donors; PBMC, peripheral blood mononuclear cells from colorectal cancer patients; TILs, tumor-infiltrating lymphocytes from colorectal cancer patients; CRC, colorectal cancer.; *, p-values < 0.05; **, p-values < 0.01 in Mann-Whitney-Wilcoxon test; middle line in box plot represents median and upper and lower sides are 1st and 3rd quantiles, respectively. Whiskers above and below the box plot represents values exceeding the 1st–3rd quantile range.CC BY · PubMed Central
Figure 3 Cytokine induced phosphorylated STAT signatures between peripheral blood mononuclear cells (PBMCs) and PBMCs co-cultured with the HCT116 cancer cell line. Phospho-flow cytometry was performed in combination for (A) IL-6 and STAT1, (B) IL-6 and STAT3, (C) IL-10 and STAT10, and (D) IL-2 and STAT5. The overall pattern between control cells and PBMCs co-cultured with HCT116 cells is similar to the pattern between control cells and TILs in Figure 2. “Con” represents control (T cells from PBMCs of healthy donors, N = 14). “D1” represents T cells from PBMCs co-cultured in direct contact with HCT116 cells (1:1, N = 8). “D10” represents T cells from PBMCs co-cultured in direct contact with HCT116 cells (1:10, N = 12). “I10” represents T cells from PBMCs co-cultured in indirect contact with HCT116 cells (1:10, N = 4).; †, p-values < 0.1; *, p-values < 0.05; **, p-values < 0.01 in Mann-Whitney-Wilcoxon test; middle line in box plot represents median and upper and lower sides are 1st and 3rd quantiles, respectively. Whiskers above and below the box plot represents values exceeding the 1st–3rd quantile range.
Figure 3 Cytokine induced phosphorylated STAT signatures between peripheral blood mononuclear cells (PBMCs) and PBMCs co-cultured with the HCT116 cancer cell line. Phospho-flow cytometry was performed in combination for (A) IL-6 and STAT1, (B) IL-6 and STAT3, (C) IL-10 and STAT10, and (D) IL-2 and STAT5. The overall pattern between control cells and PBMCs co-cultured with HCT116 cells is similar to the pattern between control cells and TILs in Figure 2. “Con” represents control (T cells from PBMCs of healthy donors, N = 14). “D1” represents T cells from PBMCs co-cultured in direct contact with HCT116 cells (1:1, N = 8). “D10” represents T cells from PBMCs co-cultured in direct contact with HCT116 cells (1:10, N = 12). “I10” represents T cells from PBMCs co-cultured in indirect contact with HCT116 cells (1:10, N = 4).; †, p-values < 0.1; *, p-values < 0.05; **, p-values < 0.01 in Mann-Whitney-Wilcoxon test; middle line in box plot represents median and upper and lower sides are 1st and 3rd quantiles, respectively. Whiskers above and below the box plot represents values exceeding the 1st–3rd quantile range.CC BY · PubMed Central
Figure 4 (A) Unsupervised cluster analysis among cytokine induced p-STAT (CIPS) signatures of peripheral blood mononuclear cells (PBMCs) from thirty colorectal cancer (CRC) patients and sixteen healthy donors. Signatures were divided into a cancer dominant group (N = 28) and a non-cancer dominant group (N = 18). (B) Principal component (PC) analysis showed PC1 and PC2 explains 43.5% and 26.4% of variance, respectively. (C) Two features with the largest Mean Decrease Gini were selected and plotted. (D) With the two features based on MeanDecreaseGini (see Materials and Methods), a simple logistic regression model was generated to distinguish CRC patients from healthy donors, and leave-one-out cross validation (LOOCV) was performed. (E–G) A receiver operating characteristic (ROC) curve was plotted for inferring the area under curve (AUC) value in training cohort, validation cohort and merged cohort. AUC values were provided in CIPS, CEA and CIPS plus CEA (G). (H) Sensitivity, specificity, positive predicted value and negative predictive value were described as 91%, 88%, 91% and 88%, respectively. Th, helper T cells; Treg, regulatory T cells; Tc, cytotoxic T cells.
Figure 4 (A) Unsupervised cluster analysis among cytokine induced p-STAT (CIPS) signatures of peripheral blood mononuclear cells (PBMCs) from thirty colorectal cancer (CRC) patients and sixteen healthy donors. Signatures were divided into a cancer dominant group (N = 28) and a non-cancer dominant group (N = 18). (B) Principal component (PC) analysis showed PC1 and PC2 explains 43.5% and 26.4% of variance, respectively. (C) Two features with the largest Mean Decrease Gini were selected and plotted. (D) With the two features based on MeanDecreaseGini (see Materials and Methods), a simple logistic regression model was generated to distinguish CRC patients from healthy donors, and leave-one-out cross validation (LOOCV) was performed. (E–G) A receiver operating characteristic (ROC) curve was plotted for inferring the area under curve (AUC) value in training cohort, validation cohort and merged cohort. AUC values were provided in CIPS, CEA and CIPS plus CEA (G). (H) Sensitivity, specificity, positive predicted value and negative predictive value were described as 91%, 88%, 91% and 88%, respectively. Th, helper T cells; Treg, regulatory T cells; Tc, cytotoxic T cells.CC BY · PubMed Central
Figure 5 (A) Graphical overview of a novel type of biomarker, the cytokine induced p-STAT (CIPS) signature. CIPS signatures are different in peripheral blood T cells when comparing colorectal cancer (CRC) patients and healthy donors. After phospho-flow cytometry analysis was performed, a simple classifier using multivariate logistic regression was validated by leave-one-out cross validation. Final performance was tested using the receiver operating characteristic (ROC) curve and the area under curve (AUC) values. (B). For an example of bedside utility of this test, a modified screening strategy for CRC could be designed for individuals unwilling to have a colonoscopy in the clinical setting. In combination with other biomarkers from different underlying biological sources, improvement in test performance is to be expected for cancer screening by non-invasive liquid biopsy; especially for individuals that are unwilling to get a colonoscopy when not presenting with any CRC risk factors.
Figure 5 (A) Graphical overview of a novel type of biomarker, the cytokine induced p-STAT (CIPS) signature. CIPS signatures are different in peripheral blood T cells when comparing colorectal cancer (CRC) patients and healthy donors. After phospho-flow cytometry analysis was performed, a simple classifier using multivariate logistic regression was validated by leave-one-out cross validation. Final performance was tested using the receiver operating characteristic (ROC) curve and the area under curve (AUC) values. (B). For an example of bedside utility of this test, a modified screening strategy for CRC could be designed for individuals unwilling to have a colonoscopy in the clinical setting. In combination with other biomarkers from different underlying biological sources, improvement in test performance is to be expected for cancer screening by non-invasive liquid biopsy; especially for individuals that are unwilling to get a colonoscopy when not presenting with any CRC risk factors.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 28 references

Cited by

See all 18

Metadata

Authors
Yun, J. W., Lee, S., Kim, H. M., Chun, S., Engleman, E. G., Kim, H. C., & Kang, E.-S.
Affiliations
  • Samsung Medical Center (KR)
  • Seoul National University (KR)
  • Samsung (South Korea) (KR)
  • Chonnam National University (KR)
  • Stanford University (US)
Corresponding author
  • Kim, Hee Cheol
  • Kang, Eun-Suk
Venue
Cancers
Publisher
MDPI AG
Published
2019-08-12
Volume
11
Issue
8
Pages
1157
ISSN
2072-6694 (ISSN-L)
OpenAlex
W2967234356
Cited by
18
References
28
Citations by year
2025: 1 · 2024: 2 · 2023: 3 · 2022: 3 · 2021: 3 · 2020: 4 · 2019: 2
FWCI
1.25
Type
journal article
Language
en
Open access
Locations
  • Cancers (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Global Ph.D. Fellowship (NRF-2016H1A2A1907938)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords
colorectal cancer, blood biomarkers, STAT phosphorylation, regulatory T cells, peripheral blood T cells, tumor-infiltrating T cells, cancer screening, immune cell signatures

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Novel Type of Blood Biomarker: Distinct Changes of Cytokine-Induced STAT Phosphorylation in Blood T Cells Between Colorectal Cancer Patients and Healthy Individuals. https://app.cochat.ai/papers/10.3390/cancers11081157
The paper
Yun, J. W., Lee, S., Kim, H. M., Chun, S., Engleman, E. G., Kim, H. C., & Kang, E.-S. (2019). A Novel Type of Blood Biomarker: Distinct Changes of Cytokine-Induced STAT Phosphorylation in Blood T Cells Between Colorectal Cancer Patients and Healthy Individuals. Cancers. https://doi.org/10.3390/cancers11081157

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.